What Is Andrographis Used for Today?
Over the last decade, a proprietary extract of andrographis (currently sold in combination with eleutherococcus) has become popular in Scandinavia as a treatment for
colds. It is beginning to become available in the United States as well. Reasonably good evidence tells us that either form of this extract can reduce the severity of cold symptoms. It may also help prevent colds.
Although we don't know how andrographis might work for colds, preliminary evidence suggests that it might stimulate immunity,
2
potentially making it useful for
general immune support.
Andrographis combined with
eleutherococcus
,
licorice
, and schisandra has shown promise for a genetic disease called familial Mediterranean fever.
24,25
Researchers have also studied andrographis as a potential treatment for
ulcerative colitis
, a type of inflammatory bowel disease. In one trial, 120 people with ulcerative colitis were randomized to andrographis extract (400 mg, 3 times daily) or the standard drug mesalazine (1,500 mg, 3 times daily).
30
After 8 weeks of treatment, the two groups had similar results.
In a randomized trial of 224 patients with ulcerative colitis, patients were randomized to 1,200 mg or 1,800 mg of andrographis a day, divided into three doses, compared to placebo. Significantly more patients taking the higher dose showed a clinical response, but not a clinical remission, compared to patients taking the placebo. Patients on the lower dose of andrographis showed no significant benefit.31
Preliminary studies in animals weakly suggest that andrographis may offer benefits for preventing
heart disease.
3,4,5
In addition, highly preliminary studies suggest that andrographis may help protect the liver from toxic injury, perhaps more successfully than the more famous liver-protective herb
milk thistle.
6,7,8
It also appears to stimulate gallbladder contraction.
9
Andrographis does not appear to have any antibacterial effects.
10
Safety Issues
Andrographis has not been associated with any side effects in human studies. In one study, participants were monitored for changes in liver function, blood counts, kidney function, and other laboratory measures of toxicity.
18
No problems were found.
However, some animal studies have raised concerns that andrographis may impair fertility. One study found that male rats became infertile when fed 20 mg of andrographis powder daily.
19
In this case, the rats stopped producing sperm and showed physical changes in some of the testicular cells involved in sperm production. Researchers also detected evidence of degeneration of other anatomical structures in the testicles. However, another study showed no evidence of testicular toxicity in male rats that were given up to 1 g per kilogram body weight daily for 60 days, so this issue remains unclear.
20
Furthermore, a human trial using the widely tested andrographis-eleutherococcus combination found no adverse effect on male fertility measurements such as sperm quality and number.
29
One group of female mice also did not fare well on high dosages of andrographis.
21
When fed 2 g per kilogram body weight daily for 6 weeks (thousands of times higher than the usual human dose), all female mice failed to get pregnant when mated with males of proven fertility. Meanwhile, of the control females, 95.2% got pregnant when mated with a similar group of male mice. Another study found a potential explanation for this in evidence that androphraphis relaxes the uterus.
23
While andrographis is probably not a useful form of birth control, these results are worrisome regarding the use of androphraphis by pregnant women.
Finally, if androphraphis does indeed stimulate the immune system, this would lead to a whole host of potential risks. The immune system is balanced on a knife edge. An immune system that is too relaxed fails to defend us from infections, but an immune system that is too active attacks healthy tissues, causing autoimmune diseases. A universal immune booster might cause or exacerbate
lupus
,
Crohn’s disease
,
asthma
, Graves’ disease,
Hashimoto’s thyroiditis
,
multiple sclerosis
, and
rheumatoid arthritis
, among other illnesses.
Safety in young children, nursing women, or those with severe liver or kidney disease has also not been established.
Also, because andrographis may stimulate gallbladder contraction, it should not be used by individuals with gallbladder disease except under physician supervision.
References
1
Hancke J, Burgos R, Caceres D, et al. A double-blind study with a new monodrug Kan Jang: decrease of symptoms and improvement in the recovery from common colds.
Phytother Res. 1995;9:559-562.
2
Puri A, Saxena R, Saxena RP, et al. Immunostimulant agents from
Andrographis paniculata. J Nat Prod.
1993;56:995-999.
3
Zhao HY, Fang WY. Antithrombotic effects of
Andrographis paniculata
nees in preventing myocardial infarction.
Chin Med J (Engl).
1991,104:770-775.
4
Zhang CY, Tan BK. Mechanisms of cardiovascular activity of
Andrographis paniculata
in the anaesthetized rat.
J Ethnopharmacol.
1997;56:97-101.
5
Wang DW, Zhao HY. Prevention of atherosclerotic arterial stenosis and restenosis after angioplasty with
Andrographis paniculata
nees and fish oil.
Chin Med J (Engl).
1994;107:464-470.
6
Visen PKS, Shukla B, Patnaik GK, et al. Andrographolide protects rat hepatocytes against paracetamol-induced damage.
J Ethnopharmacol.
1993;40:131-136.
7
Kapil A, Koul IB, Banerjee SK, et al. Antihepatotoxic effects of major diterpenoid constituents of
Andrographis paniculata.Biochem Pharmacol.
1993;46:182-185.
8
Handa SS, Sharma A. Hepatoprotective activity of andrographolide from
Andrographis paniculata
against carbontetrachloride.
Indian J Med Res.
1990;92:276-283.
9
Shukla B, Visen PKS, Patnaik GK, et al. Choleretic effect of andrographolide in rats and guinea pigs.
Planta Med.
1992;58:146-149.
10
Leelarasamee A, Trakulsomboon S, Sittisomwong N. Undetectable anti-bacterial activity of
Andrographis paniculata
(Burma) wall. ex ness.
J Med Assoc Thai.
1990;73:299-304.
11
Caceres DD, Hancke JL, Burgos RA, et al. Use of visual analogue scale measurements (VAS) to assess the effectiveness of standardized
Andrographis paniculata
extract SHA-10 in reducing the symptoms of common cold. A randomized double blind-placebo study.
Phytomedicine.
1999;6:217-223.
12
Melchior J, Palm S, Wikman G. Controlled clinical study of standardized
Andrographis paniculata
extract in common cold—a pilot trial.
Phytomedicine.
1996/1997;34:315-318.
13
Hancke J, Burgos R, Caceres D, et al. A double-blind study with a new monodrug Kan Jang: decrease of symptoms and improvement in the recovery from common colds.
Phytother Res. 1995;9:559-562.
14
Caceres DD, Hancke JL, Burgos RA, et al. Use of visual analogue scale measurements (VAS) to assess the effectiveness of standardized
Andrographis paniculata
extract SHA-10 in reducing the symptoms of common cold. A randomized double blind-placebo study.
Phytomedicine. 1999;6:217-223.
15
Melchior J, Spasov AA, Ostrovskij OV, et al. Double-blind, placebo-controlled pilot and phase III study of activity of standardized
Andrographis paniculata
Herba Nees extract fixed combination (Kan jang) in the treatment of uncomplicated upper-respiratory tract infection.
Phytomedicine. 2000;7:341-350.
16
Thamlikitkul V, Dechatiwongse T, Theerapong S, et al. Efficacy of
Andrographis paniculata
(Nees) for pharyngotonsillitis in adults.
J Med Assoc Thai.1991;74:437-442.
17
Caceres DD, Hancke JL, Burgos RA, et al. Prevention of common colds with
Andrographis paniculata
dried extract: a pilot double blind trial.
Phytomedicine
1997;4:101-104.
18
Hancke J, Burgos R, Caceres D, et al. A double-blind study with a new monodrug Kan Jang: decrease of symptoms and improvement in the recovery from common colds.
Phytother Res. 1995;9:559-562.
19
Akbarsha MA, Manivannan B, Shahul Hamid K, et al. Antifertility effect of
Andrographis paniculata
(Nees) in male albino rat.
Indian J Exp Biol. 1990;28:421-426.
20
Burgos RA, Caballero EE, Sanchez NS, et al. Testicular toxicity assessment of
Andrographis paniculata
dried extract in rats.
J Ethnopharmacol. 1997;58:219-224.
21
Zoha MS, Hussain AHM, Choudhury SAR. Antifertility effect of
Andrographis paniculata
in mice.
Bangladesh Med Res Counc Bull. 1989;15:34-37.
22
Gabrielian ES, Shukarian AK, Goukasova GI, et al. A double blind, placebo-controlled study of
Andrographis paniculata
fixed combination Kan Jang in the treatment of acute upper respiratory tract infections including sinusitis.
Phytomedicine. 2002;9:589-597.
23
Burgos RA, Aguila MJ, Santiesteban ET.
Andrographis paniculata
(Nees) induces relaxation of uterus by blocking voltage operated calcium channels and inhibits Ca(+2) influx.
Phytother Res. 2001;15:235-239.
24
Panossian A, Hambartsumyan M, Panosyan L, et al. Plasma nitric oxide level in familial Mediterranean fever and its modulations by Immuno-Guard.
Nitric Oxide. 2003;9:103-110.
25
Amaryan G, Astvatsatryan V, Gabrielyan E, et al. Double-blind, placebo-controlled, randomized, pilot clinical trial of ImmunoGuard—a standardized fixed combination of
Andrographis paniculata
Nees, with
Eleutherococcus senticosus
Maxim,
Schizandra chinensis
Bail, and
Glycyrrhiza glabra L. extracts in patients with familial Mediterranean fever.
Phytomedicine. 2003;10:271-285.
26
Coon JT, Ernst E.
Andrographis paniculata
in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy.
Planta Med. 2004;70:293-298.
27
Spasov AA, Ostrovskij OV, Chernikov MV, et al. Comparative controlled study of
Andrographis paniculata
fixed combination, Kan Jang(R) and an echinacea preparation as adjuvant, in the treatment of uncomplicated respiratory disease in children.
Phytother Res. 2004;18:47-53.
28
Kulichenko LL, Kireyeva LV, Malyshkina EN, et al. A randomized, controlled study of Kan Jang versus amantadine in the treatment of influenza in Volgograd.
J Herb Pharmcother. 2003;3:77-92.
29
Mkrtchyan A, Panosyan V, Panossian A, et al. A phase I clinical study of Andrographis paniculata fixed combination Kan Jang versus ginseng and valerian on the semen quality of healthy male subjects.
Phytomedicine. 2005;12:403-409
30
Tang T, Targan SR, Li ZS, Xu C, Byers VS, Sandborn WJ. Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis—a double-blind comparison with sustained release mesalazine.
Aliment Pharmacol Ther.
2011;33(2):194-202.
31
Sandborn WJ, Targan SR, Byers VS, et al. Andrographis paniculata extract (HMPL-004) for active ulcerative colitis.
Am J Gastroenterol. 2013;108(1):90-98.